| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | SCHEDULE 13G |
| 09 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
TORONTO and TOKYO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, and KYORIN Pharmaceuti... |
| 05 Nov 2026 |
Form 4: Nijhawan Pardeep, Director
Received 18,677 shares as a grant or award |
| 04 Nov 2026 | SCHEDULE 13G/A |
| 29 Oct 2026 |
Form 4: Nijhawan Pardeep, Director
Received 27,602 shares as a grant or award |
| 23 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 15 Oct 2026 |
8-K: Other Events
On October 15, 2026, Edesa Biotech, Inc. (the “Company”) reported that the U.S. Food and Drug Administration (“FDA”) has cleared the Company's Investigational New Drug (“IND”) application for its Phase 2 clinical study of EB06 in vitilig... |
| 06 Oct 2026 |
Form 4: Nijhawan Pardeep, Director
Received 6,893 shares as a grant or award |
| 01 Sep 2026 |
Form 4: Nijhawan Pardeep, Director
Received 5,714 shares as a grant or award |
| 26 Aug 2026 | SCHEDULE 13G |
| 25 Aug 2026 | SCHEDULE 13D/A |
| 25 Aug 2026 | SCHEDULE 13D/A |
| 20 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
Pre-Funded Warrants to Purchase up to 675,000 Common Shares, |
| 20 Aug 2026 | 424B5 |
| 19 Aug 2026 | 424B5 |
| 13 Aug 2026 | FORM 10-Q |
| 13 Aug 2026 |
8-K: Results of Operations and Financial Condition
TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results ... |
| 04 Aug 2026 |
Form 4: Nijhawan Pardeep, Director
Received 5,324 shares as a grant or award |
Loading...